E2F8 and breast cancer: Together, these findings implicate hsa-let-7b-5p as a critical post-transcriptional regulator of ESPL1 and highlight a potential ceRNA network involving hsa-let-7b-5p, E2F8, and ESPL1 that may drive tumor progression and poor prognosis in breast cancer.